Watrix Pharmaceuticals Private Limited

Watrix Pharmaceuticals Private Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
CIN U51397KA2018PTC115785 Incorporated 29 August 2018 ROC Bangalore HQ Bangalore, Karnataka, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2022
₹2.01 Cr
▲ 29% YoY
Net profit · FY 2022
₹2.85 Lakh
Net margin 1.4%
EBITDA · FY 2022
₹10.06 Lakh
EBITDA margin 5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Watrix Pharmaceuticals Private Limited

Data last updated:

Watrix Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 August 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51397KA2018PTC115785. Its GSTIN is 36AACCW2598N1ZL (Telangana).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Pradhyumna Garimidi and Atmakuri Sandhya Rani.

Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Flat.No.205 Gas Wave Woods K.No.534 Sy.No.76 Doddanekundi, Bangalore, Karnataka, India – 560037.

As per the financials filed for FY 2022, the company reported a revenue of ₹2.01 Cr, a growth of 29% compared to the previous year. For the same year it recorded a net profit of ₹2.85 Lakh (net margin 1.4%) and EBITDA of ₹10.06 Lakh (EBITDA margin 5%). Revenue has grown at a compounded annual rate (CAGR) of 430% over three years.

For more details, the company can be reached via its website watrixpharma.com.

Company Details of Watrix Pharmaceuticals Private Limited
CIN U51397KA2018PTC115785
Registration Number 115785
Incorporation Date 29 August 2018
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    Flat.No.205 Gas Wave Woods K.No.534 Sy.No.76 Doddanekundi, Bangalore, Karnataka, India – 560037
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Watrix Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Watrix Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Watrix Pharmaceuticals Private Limited in one report.

Financials from FY 2019 Directors & ownership Charges & compliance

Business Activity of Watrix Pharmaceuticals Private Limited

The main business activity of Watrix Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Watrix Pharmaceuticals Private Limited FY 2022 filings available

Watrix Pharmaceuticals Private Limited reported revenue of ₹2.01 Cr (up 29% YoY) for FY 2022.

Revenue · FY 2022
₹2.01 Cr ▲ 29%
Net profit · FY 2022
₹2.85 Lakh margin 1.4%
EBITDA · FY 2022
₹10.06 Lakh margin 5%

Compounded Annual Growth Rate (CAGR) of Watrix Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▲ 29%
3 years · compounded
▲ 430%
EBITDA CAGR growth
1 year
▲ 107%
3 years · compounded
▲ 61%

Revenue has grown at a compounded annual rate (CAGR) of 430% over three years, including 29% growth in the latest year. EBITDA rose 107% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Watrix Pharmaceuticals Private Limited

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations••••••••••••••••
Other Income••••••••••••••••
Total Revenue••••••••••••••••
Cost of Materials Consumed••••••••••••••••
Employee Benefit Expense••••••••••••••••
Finance Costs••••••••••••••••
Depreciation and Amortisation••••••••••••••••
Other Expenses••••••••••••••••
Total Expenses••••••••••••••••
EBITDA₹10.06 Lakh••••••••••••
Profit Before Tax••••••••••••••••
Tax Expense••••••••••••••••
Net Profit (PAT)₹2.85 Lakh••••••••••••
Balance Sheet
Share Capital••••••••••••••••
Reserves and Surplus••••••••••••••••
Net Worth (Total Equity)••••••••••••••••
Long-term Borrowings••••••••••••••••
Short-term Borrowings••••••••••••••••
Trade Payables••••••••••••••••
Total Liabilities••••••••••••••••
Fixed Assets••••••••••••••••
Investments••••••••••••••••
Inventories••••••••••••••••
Trade Receivables••••••••••••••••
Cash and Bank Balance••••••••••••••••
Total Assets••••••••••••••••

Financial Ratios of Watrix Pharmaceuticals Private Limited

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin5%••••••••••••
Net Profit Margin1.4%••••••••••••
Return on Equity (ROE)••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••
Return on Assets (ROA)••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••
Quick Ratio••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••
Interest Coverage Ratio••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••
Receivable Days••••••••••••••••
Payable Days••••••••••••••••
Inventory Days••••••••••••••••
Revenue Growth••••••••••••••••
Net Profit Growth••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Watrix Pharmaceuticals are in the company report.

Premium access

Financial statements from FY 2019

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Watrix Pharmaceuticals Private Limited

Watrix Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Vianex Pharmaceuticals Private Limited₹2.03 Cr (FY 2024)••••••••50.0%••••Neyyattinkara, Kerala, India
Pavittar Pharmaceuticals Private Limited₹2.03 Cr (FY 2023)••••••••97.0%••••Chandigarh, India
Clementia Pharmaceuticals Private Limited₹2.02 Cr (FY 2025)••••••••3.0%••••Thane, Maharashtra, India
Vogue Pharmaceuticals Private Limited₹2.02 Cr (FY 2025)••••••••-5.0%••••New Delhi, Delhi, India
Oncomed Pharmaceuticals India Private Limited₹2.02 Cr (FY 2025)••••••••-54.0%••••Patna, Bihar, India
Watrix Pharmaceuticals Private Limited this company₹2.01 Cr (FY 2022)••••••••29.0%••••Bangalore, Karnataka, India
Veasley Pharmaceuticals Private Limited₹2.01 Cr (FY 2024)••••••••64.0%••••Panchkula, Haryana, India
Parakit Pharmaceuticals Private Limited₹2 Cr (FY 2024)••••••••••••Thane, Maharashtra, India
Amrutam Pharmaceuticals Private Limited₹1.98 Cr (FY 2024)••••••••-11.0%••••Gwalior, Madhya Pradesh, India
BLBK Pharmaceuticals Private Limited₹1.98 Cr (FY 2025)••••••••-27.0%••••Delhi, India
Praxis Health Care & Pharmaceuticals Private Limited₹1.98 Cr (FY 2024)••••••••-2.0%••••Jaipur, Rajasthan, India

Peers are the five companies nearest above and the five nearest below Watrix Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Watrix Pharmaceuticals Private Limited

Watrix Pharmaceuticals Private Limited is audited by G SRINIVASULU & CO for the financial year 2020.

NameStatusAppointment DateCessation Date
G SRINIVASULU & COLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Watrix Pharmaceuticals Private Limited

Watrix Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Pradhyumna GarimidiDirector27 Jan 20215 Years 8 MonthsCurrent
Atmakuri Sandhya RaniDirector21 Dec 20223 Years 9 MonthsCurrent
Sai Sree Labhya SureDirector21 Dec 20223 Years 9 MonthsCurrent

Ownership and Shareholding of Watrix Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Watrix Pharmaceuticals Private Limited

Watrix Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Watrix Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to Watrix Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Watrix Pharmaceuticals Private Limited

Watrix Pharmaceuticals Private Limited has 7 board changes on record since 2019: 3 appointments and 4 cessations. The latest: Atmakuri Sandhya Rani was appointed as Director on 21 Dec 2022.

Appointed
Atmakuri Sandhya Rani was appointed as Director.
Appointed
Sai Sree Labhya Sure was appointed as Director.
Ceased
Samanuri Mahesh Varma ceased to be Director.
Ceased
Yarraiah Idapalapati ceased to be Director.
AGM
Watrix Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Filing
Watrix Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Bangalore.
Ceased
Pradhyumna Garimidi ceased to be Additional Director.
Appointed
Pradhyumna Garimidi was appointed as Director.
Ceased
Venkatasubbaramasarma Jonnalagadda ceased to be Director.
Incorporation
29 Aug 2018
Watrix Pharmaceuticals Private Limited was registered on 29 Aug 2018 with Roc Bangalore & aged 8 years 1 month as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Watrix Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Watrix Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Watrix Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Watrix Pharmaceuticals Private Limited

Watrix Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AACCW2598N1ZLTelanganaActive28 Dec 2018
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Watrix Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Watrix Pharmaceuticals Private Limited

Watrix Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 August 2018 (8+ years old) and is registered under CIN U51397KA2018PTC115785.

Watrix Pharmaceuticals reported revenue of ₹2.01 Cr for FY 2022 (up 29% YoY).

Watrix Pharmaceuticals has 3 current directors:

Watrix Pharmaceuticals reported a net profit of ₹2.85 Lakh (net margin 1.4%) and EBITDA of ₹10.06 Lakh (EBITDA margin 5%) for FY 2022, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Watrix Pharmaceuticals is 430% over three years. In the latest year (FY 2022) revenue rose 29%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Watrix Pharmaceuticals is 36AACCW2598N1ZL, registered in Telangana.

The CIN (Corporate Identification Number) of Watrix Pharmaceuticals is U51397KA2018PTC115785. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Watrix Pharmaceuticals was incorporated on 29 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Bangalore.

The peers of Watrix Pharmaceuticals by revenue are Vianex Pharmaceuticals Private Limited, Pavittar Pharmaceuticals Private Limited, Clementia Pharmaceuticals Private Limited, Vogue Pharmaceuticals Private Limited, Oncomed Pharmaceuticals India Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).

Atmakuri Sandhya Rani was appointed as Director on 21 Dec 2022. Sai Sree Labhya Sure was appointed as Director on 21 Dec 2022. Samanuri Mahesh Varma ceased to be Director on 21 Dec 2022. Watrix Pharmaceuticals has 7 board changes on record in total.

Watrix Pharmaceuticals can be reached through the website watrixpharma.com. Its registered office is in Bangalore, Karnataka, India.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available